about
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.
Read More
2.03
0.02
(1.00%)
19,730
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
BeyondSpring Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..